Qiming Medical-B (02500.HK) released its interim results, with a shareholder's net loss of 135 million yuan, a year-on-year decrease of 34.7%.

Tencent Finance News: Qiming Medical-B (02500.HK) released its interim performance for the six months ending June 30, 2025. The group's revenue was 187 million yuan, a decrease of 18.9% year-on-year. Shareholders' net loss was 135 million yuan, narrowing by 34.7% year-on-year. Loss per share was 0.31 yuan.